These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15618590)

  • 21. Safety of biweekly α
    Greulich T; Chlumsky J; Wencker M; Vit O; Fries M; Chung T; Shebl A; Vogelmeier C; Chapman KR; McElvaney NG;
    Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30237305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin.
    Piitulainen E; Bernspång E; Björkman S; Berntorp E
    Eur J Clin Pharmacol; 2003 Jun; 59(2):151-6. PubMed ID: 12728289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-1-antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokinetics.
    Soy D; de la Roza C; Lara B; Esquinas C; Torres A; Miravitlles M
    Thorax; 2006 Dec; 61(12):1059-64. PubMed ID: 16928711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of alpha-1 antitrypsin deficiency.
    Ranes J; Stoller JK
    Semin Respir Crit Care Med; 2005 Apr; 26(2):154-66. PubMed ID: 16088434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-1-antitrypsin augmentation treatment: does one size fit all?
    Stolk J
    Thorax; 2006 Dec; 61(12):1034. PubMed ID: 17114371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the evidence that augmentation therapy helps asthma: are storks really responsible for new babies?
    Stoller JK
    Monaldi Arch Chest Dis; 2008 Dec; 69(4):155-6. PubMed ID: 19350836
    [No Abstract]   [Full Text] [Related]  

  • 27. Intravenous alpha1-antitrypsin in a child with deficiency and severe lung disease.
    Griese M; Brüggen H
    Eur Respir J; 2009 Jul; 34(1):278-9. PubMed ID: 19567611
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term augmentation therapy with alpha-1 antitrypsin in an MZ-AAT severe persistent asthma.
    Blanco I; Canto H; Flóres J; Camblor C; Cárcaba V; de Serres FJ; Janciauskiene S; Bustillo EF
    Monaldi Arch Chest Dis; 2008 Dec; 69(4):178-82. PubMed ID: 19350840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-1 antitrypsin Null mutations and severity of emphysema.
    Fregonese L; Stolk J; Frants RR; Veldhuisen B
    Respir Med; 2008 Jun; 102(6):876-84. PubMed ID: 18353624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comment: comparisons of Aralast and Prolastin, alpha1-protease inhibitors for treatment of alpha1-antitrypsin deficiency.
    Petteway SR
    Ann Pharmacother; 2006 Feb; 40(2):353-4; author reply 354. PubMed ID: 16449545
    [No Abstract]   [Full Text] [Related]  

  • 31. Alpha-1-antitrypsin replacement therapy: current status.
    Abusriwil H; Stockley RA
    Curr Opin Pulm Med; 2006 Mar; 12(2):125-31. PubMed ID: 16456382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung volume reduction surgery in patients with emphysema and alpha-1 antitrypsin deficiency.
    Stoller JK; Gildea TR; Ries AL; Meli YM; Karafa MT;
    Ann Thorac Surg; 2007 Jan; 83(1):241-51. PubMed ID: 17184672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of proteases, plasminogen activators, fibrin fibrinogen degradation products and fibrinopeptides in the growth and development of neoplasms and neoplasm metastases].
    Farbiszewski R
    Postepy Hig Med Dosw; 1984; 38(2):133-55. PubMed ID: 6393101
    [No Abstract]   [Full Text] [Related]  

  • 34. Heritability of lung function in severe alpha-1 antitrypsin deficiency.
    DeMeo DL; Campbell EJ; Brantly ML; Barker AF; Eden E; McElvaney NG; Rennard SI; Stocks JM; Stoller JK; Strange C; Turino G; Sandhaus RA; Silverman EK
    Hum Hered; 2009; 67(1):38-45. PubMed ID: 18931508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector.
    Lu Y; Choi YK; Campbell-Thompson M; Li C; Tang Q; Crawford JM; Flotte TR; Song S
    J Gene Med; 2006 Jun; 8(6):730-5. PubMed ID: 16518879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Despite challenges, new treatments abound for AAT deficiency.
    Morrow T
    Manag Care; 2004 Feb; 13(2):48-9. PubMed ID: 15004931
    [No Abstract]   [Full Text] [Related]  

  • 37. Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthma.
    van Veen IH; ten Brinke A; van der Linden AC; Rabe KF; Bel EH
    Respir Med; 2006 Sep; 100(9):1534-9. PubMed ID: 16476537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Should we administer replacement therapy to patients with alpha-1-antitrypsin deficit?].
    Miravitlles M
    Arch Bronconeumol; 1998 Mar; 34(3):109-11. PubMed ID: 9611633
    [No Abstract]   [Full Text] [Related]  

  • 39. [Alpha-1-proteinase inhibitor deficiency. Substitution slows degradation of lung tissue].
    Stiefelhagen P
    Med Monatsschr Pharm; 2014 Jul; 37(7):261-2. PubMed ID: 25065163
    [No Abstract]   [Full Text] [Related]  

  • 40. [Difficulties in controlled inhalation of alpha 1-protease inhibitor].
    Brand P; Maas Enriquez M; Meyer T; Scheuch G; Weber N
    Pneumologie; 2003 Mar; 57(3):153-8. PubMed ID: 12632295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.